A Phase Ⅲ Clinical Study of MIL62 in Primary Membranous Nephropathy

NCT05862233 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Membranous Nephropathy

Interventions

DRUG: MIL62
DRUG: Cyclosporine

Sponsor

Beijing Mabworks Biotech Co., Ltd.